发文分析
近年国家/地区发文量统计
| 国家/地区 | 数量 |
|---|---|
| USA | 42 |
| England | 26 |
| CHINA MAINLAND | 15 |
| Iran | 14 |
| Canada | 10 |
| GERMANY (FED REP GER) | 10 |
| Netherlands | 10 |
| Australia | 8 |
| Sweden | 7 |
| Switzerland | 7 |
近年机构发文量统计
| 机构 | 数量 |
|---|---|
| HARVARD UNIVERSITY | 11 |
| SHIRAZ UNIVERSITY OF MEDICAL SCIENCE | 6 |
| UNIVERSITY OF LONDON | 6 |
| IRAN UNIVERSITY OF MEDICAL SCIENCES | 5 |
| WORLD HEALTH ORGANIZATION | 5 |
| ADDIS ABABA UNIVERSITY | 4 |
| GLAXOSMITHKLINE | 4 |
| KAROLINSKA INSTITUTET | 4 |
| KERMAN UNIVERSITY OF MEDICAL SCIENCES | 4 |
| UNIVERSITY OF BERGEN | 4 |
近年文章引用他刊数据
| 文章名称 | 引用次数 |
|---|---|
| Cost-effectiveness of tiotropium versus omalizumab for u... | 10 |
| Econometric estimation of WHO-CHOICE country-specific co... | 10 |
| Catastrophic expenditures and impoverishment due to out-... | 10 |
| Primary and secondary prevention interventions for cardi... | 9 |
| The acceptance and willingness to pay (WTP) for hypothet... | 8 |
| Cost-effective interventions for breast cancer, cervical... | 7 |
| Effects of prescription restrictive interventions on ant... | 7 |
| Personalized medicine in colorectal cancer diagnosis and... | 6 |
| Technical efficiency of public district hospitals in Ban... | 6 |
| Incorporating MCDA into HTA: challenges and potential so... | 6 |
近年被他刊引用数据
| 期刊名称 | 引用次数 |
|---|---|
| VALUE HEALTH | 11 |
| EUR J HEALTH ECON | 10 |
| BMJ GLOB HEALTH | 9 |
| HEALTH POLICY PLANN | 9 |
| PHARMACOECONOMICS | 9 |
| LANCET GLOB HEALTH | 8 |
| SOC SCI MED | 7 |
| COST EFFECT RESOUR A | 6 |
| DISASTERS | 6 |
| EXPERT REV PHARM OUT | 6 |